Resistance Rates by Bacteria and Region Source: ICMR Antimicrobial Resistance Surveillance Network (AMRSN) Annual Report 2024, Ministry of Health National Action Plan on Antimicrobial Resistance (NAP-AMR 2.0) November 2025, National Centre for Disease Control (NCDC) AMR Containment Programme, State Health Departments (Delhi, Maharashtra, Tamil Nadu, Karnataka, West Bengal), WHO Strategic and Technical Advisory Group on Antimicrobial Resistance (STAG-AMR), ICMR National Antibiotic Stewardship Program
Fluorescein solution can be left in the fridge at 4C for 1 month for repeated uses
166, 168, 446 Piersanti, A
Ongoing refills require a clinical follow-up around week 8, which keeps a licensed provider actively monitoring progress rather than auto-renewing indefinitely
Current clinical guidance recommends: Discontinuing Wegovy at least 2 months before attempting conception to allow full clearance Continuing reliable contraception until actively trying to conceive, given that weight loss may restore ovulation unexpectedly Stopping the medication immediately and consulting a provider upon confirmed pregnancy For women with PCOS planning pregnancy, coordinating a transition plan with both gynecology and endocrinology before stopping Wegovy Wegovy and breastfeeding No human safety data exists for semaglutide use during breastfeeding
